Literature DB >> 3550079

Wastage of drug from nebulisers: a review.

M M Clay, S W Clarke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3550079      PMCID： PMC1290632          DOI： 10.1177/014107688708000115

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  6 in total

1.  Efficiency of nebulizers for depositing saline in human lung.

Authors:  T Asmundsson; R F Johnson; K H Kilburn; J K Goodrich
Journal:  Am Rev Respir Dis       Date:  1973-09

2.  Assessment of jet nebulisers for lung aerosol therapy.

Authors:  M M Clay; D Pavia; S P Newman; T Lennard-Jones; S W Clarke
Journal:  Lancet       Date:  1983-09-10       Impact factor: 79.321

Review 3.  How should a pressurized beta-adrenergic bronchodilator be inhaled?

Authors:  S P Newman; D Pavia; S W Clarke
Journal:  Eur J Respir Dis       Date:  1981-02

4.  Factors influencing the size distribution of aerosols from jet nebulisers.

Authors:  M M Clay; D Pavia; S P Newman; S W Clarke
Journal:  Thorax       Date:  1983-10       Impact factor: 9.139

5.  The importance of particle size in response to inhaled bronchodilators.

Authors:  P J Rees; T J Clark; F Morén
Journal:  Eur J Respir Dis Suppl       Date:  1982

6.  Misplaced confidence in nebulised bronchodilators in severe asthmatic attacks.

Authors:  I Gregg
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-02
  6 in total
  10 in total

1.  Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.

Authors:  V L Silkstone; H S Tomlinson; S A Corlett; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

2.  Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.

Authors:  J H Dennis; S C Stenton; J R Beach; A J Avery; E H Walters; D J Hendrick
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

3.  Management of severe obstructive pulmonary disease with inhaled bronchodilator treatment in a horse.

Authors:  A M Hoffman; L Viel; D B Tesarowski; J D Baird
Journal:  Can Vet J       Date:  1993-08       Impact factor: 1.008

4.  Local anaesthetic toxicity during an awake tracheal intubation course.

Authors:  F Pearson; P Chiam
Journal:  Anaesth Rep       Date:  2020-03-02

Review 5.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

6.  The rapid and effective administration of a beta 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers.

Authors:  D B Tesarowski; L Viel; W N McDonell; M T Newhouse
Journal:  Can Vet J       Date:  1994-03       Impact factor: 1.008

Review 7.  Pharmacokinetic optimisation of asthma treatment.

Authors:  A M Taburet; B Schmit
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

Review 8.  Aerosol delivery systems for bronchial asthma.

Authors:  P L Ariyananda; J E Agnew; S W Clarke
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

9.  Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization.

Authors:  Anushi E Rajapaksa; Jenny J Ho; Aisha Qi; Rob Bischof; Tri-Hung Nguyen; Michelle Tate; David Piedrafita; Michelle P McIntosh; Leslie Y Yeo; Els Meeusen; Ross L Coppel; James R Friend
Journal:  Respir Res       Date:  2014-05-20

10.  Efficacy of atomised local anaesthetic versus transtracheal topical anaesthesia for awake fibreoptic intubation.

Authors:  Bindu K Vasu; Sunil Rajan; Jerry Paul; Lakshmi Kumar
Journal:  Indian J Anaesth       Date:  2017-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.